Article
Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.
Journal of virology - 1 Mar 2003
Dybul Mark, Daucher Marybeth, Jensen Mark A, Hallahan Claire W, Chun Tae-Wook, Belson Michael, Hidalgo Bertha, Nickle David C, Yoder Christian, Metcalf Julia A, Davey Richard T, Ehler Linda, Kress-Rock Diane, Nies-Kraske Elizabeth, Liu Shuying, Mullins James I, Fauci Anthony S
Abstract excerpt
Various strategies of interrupting highly active antiretroviral therapy (HAART) are being investigated for the treatment of human immunodeficiency virus (HIV) infection. Interruptions of greater than 2 weeks frequently result in rebound of plasma HIV RNA. In order to discern changes in the viral population that might occur during cycles of treatment interruption, we evaluated the homology of HIV-1 envelope gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
